These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25274738)

  • 21. The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.
    Matoulkova E; Michalova E; Vojtesek B; Hrstka R
    RNA Biol; 2012 May; 9(5):563-76. PubMed ID: 22614827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate.
    Polenkowski M; Allister AB; Burbano de Lara S; Pierce A; Geary B; El Bounkari O; Wiehlmann L; Hoffmann A; Whetton AD; Tamura T; Tran DDH
    iScience; 2023 Jan; 26(1):105784. PubMed ID: 36590164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumoylation modulates the assembly and activity of the pre-mRNA 3' processing complex.
    Vethantham V; Rao N; Manley JL
    Mol Cell Biol; 2007 Dec; 27(24):8848-58. PubMed ID: 17923699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THOC5/FMIP, an mRNA export TREX complex protein, is essential for hematopoietic primitive cell survival in vivo.
    Mancini A; Niemann-Seyde SC; Pankow R; El Bounkari O; Klebba-Färber S; Koch A; Jaworska E; Spooncer E; Gruber AD; Whetton AD; Tamura T
    BMC Biol; 2010 Jan; 8():1. PubMed ID: 20051105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An ataxia-telangiectasia-mutated (ATM) kinase mediated response to DNA damage down-regulates the mRNA-binding potential of THOC5.
    Ramachandran S; Tran DD; Klebba-Faerber S; Kardinal C; Whetton AD; Tamura T
    RNA; 2011 Nov; 17(11):1957-66. PubMed ID: 21937706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human THO coordinates transcription termination and subsequent transcript release from the HSP70 locus.
    Katahira J; Ishikawa H; Tsujimura K; Kurono S; Hieda M
    Genes Cells; 2019 Apr; 24(4):272-283. PubMed ID: 30721563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A core complex of CPSF73, CPSF100, and Symplekin may form two different cleavage factors for processing of poly(A) and histone mRNAs.
    Sullivan KD; Steiniger M; Marzluff WF
    Mol Cell; 2009 May; 34(3):322-32. PubMed ID: 19450530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of AGR2 expression via 3'UTR shortening.
    Matoulkova E; Sommerova L; Pastorek M; Vojtesek B; Hrstka R
    Exp Cell Res; 2017 Jul; 356(1):40-47. PubMed ID: 28408318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mRNA 3'end processing: A tale of the tail reaches the clinic.
    Hollerer I; Grund K; Hentze MW; Kulozik AE
    EMBO Mol Med; 2014 Jan; 6(1):16-26. PubMed ID: 24408965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative elongation factor NELF controls transcription of immediate early genes in a stimulus-specific manner.
    Fujita T; Piuz I; Schlegel W
    Exp Cell Res; 2009 Jan; 315(2):274-84. PubMed ID: 19014935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plant-like mechanism coupling m6A reading to polyadenylation safeguards transcriptome integrity and developmental gene partitioning in
    Farhat DC; Bowler MW; Communie G; Pontier D; Belmudes L; Mas C; Corrao C; Couté Y; Bougdour A; Lagrange T; Hakimi MA; Swale C
    Elife; 2021 Jul; 10():. PubMed ID: 34263725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SRm160 splicing coactivator promotes transcript 3'-end cleavage.
    McCracken S; Lambermon M; Blencowe BJ
    Mol Cell Biol; 2002 Jan; 22(1):148-60. PubMed ID: 11739730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From polyadenylation to splicing: Dual role for mRNA 3' end formation factors.
    Misra A; Green MR
    RNA Biol; 2016; 13(3):259-64. PubMed ID: 26891005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations.
    Danckwardt S; Gehring NH; Neu-Yilik G; Hundsdoerfer P; Pforsich M; Frede U; Hentze MW; Kulozik AE
    Blood; 2004 Jul; 104(2):428-35. PubMed ID: 15059842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo.
    Gu B; Eick D; Bensaude O
    Nucleic Acids Res; 2013 Feb; 41(3):1591-603. PubMed ID: 23275552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.
    Ogami K; Hosoda N; Funakoshi Y; Hoshino S
    Oncogene; 2014 Jan; 33(1):55-64. PubMed ID: 23178487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.
    Ogorodnikov A; Levin M; Tattikota S; Tokalov S; Hoque M; Scherzinger D; Marini F; Poetsch A; Binder H; Macher-Göppinger S; Probst HC; Tian B; Schaefer M; Lackner KJ; Westermann F; Danckwardt S
    Nat Commun; 2018 Dec; 9(1):5331. PubMed ID: 30552333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.
    Creemers EE; Bawazeer A; Ugalde AP; van Deutekom HW; van der Made I; de Groot NE; Adriaens ME; Cook SA; Bezzina CR; Hubner N; van der Velden J; Elkon R; Agami R; Pinto YM
    Circ Res; 2016 Feb; 118(3):433-8. PubMed ID: 26671978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.